NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Aerobic Capacity Following Long Duration International Spaces Station (ISS) Missions: Preliminary ResultsMaximum oxygen uptake (VO2max) is reduced immediately following space flights lasting <15 d, but has not been measured following long-duration missions. The purpose of this study is to measure VO2max and maximum work rate (WRmax) data from astronauts following ISS flights (91 to 188 d). Methods: Five astronauts [3 M, 2 F: 47+/-6 yr, 174+/-6 cm, 71.9+/-10.9 kg (mean +/- SD)] have participated in the study. Subjects performed upright cycle exercise tests to symptom-limited maximum. An initial test was done approx.270 d before flight to establish work rates for subsequent tests. Subsequent tests, conducted approx.45 d before flight and repeated on the first or second day (R+1/2) and at approx.10 d (R+10) following landing, consisted of 3 5 min stages designed to elicit 25%, 50%, and 75% of preflight VO2max, followed by 25 W(dot)/min increases. VO2, WR, and heart rate (HR) were measured using the ISS Portable Pulmonary Function System [Damec, Odense, DK]. Descriptive statistics are reported. Results: On R+1/2 mean VO2max decreased compared to preflight (Pre: 2.98+/-0.99, R+1/2: 2.63+/-0.56 L(dot)/min); 4 of 5 subjects demonstrated a loss of > 6%. WRmax also decreased on R+1/2 compared to preflight (Pre: 245+/-69, R+1/2: 210+/-45 W). On R+10, VO2max was 2.86+/-0.62 L(dot)/min, with 2 subjects still demonstrating a loss of > 6% from preflight. WRmax on R+10 was 240+/-49 W. HRmax did not change from pre to post-flight. Conclusions: These preliminary results, from the first 5 of 12 planned subjects of an ongoing ISS study, suggest that the majority of astronauts will experience a decrease in VO2max after long-duration space-flight. Interestingly, the two astronauts with the highest preflight VO2max had the greatest loss on R+1/2, and the astronaut with the lowest preflight VO2max increased by 13%. Thus, maintenance of VO2max may be more difficult in astronauts who have a high aerobic capacity, perhaps requiring more intense in-flight exercise countermeasure prescriptions.
Document ID
20100037247
Acquisition Source
Johnson Space Center
Document Type
Conference Paper
Authors
Moore, Alan D.
(Wyle Integrated Science and Engineering Group Houston, TX, United States)
Lee, S.M.C.
(Wyle Integrated Science and Engineering Group Houston, TX, United States)
Everett, M.E.
(Houston Univ. Houston, TX, United States)
Guined, J.R.
(Houston Univ. Houston, TX, United States)
Knudsen, P.
(Damec Research Aps Odense, Denmark)
Date Acquired
August 25, 2013
Publication Date
January 1, 2010
Subject Category
Aerospace Medicine
Report/Patent Number
JSC-CN-21992
Meeting Information
Meeting: 82nd Annual Scientific Meeting of the Aerospace Medical Association
Location: Anchorage, AK
Country: United States
Start Date: May 8, 2011
End Date: May 12, 2011
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available